Ortanol 20 Plus (Omeprazole)

Omeprazole works by irreversibly blocking the H+/K+‑ATPase enzyme, also known as the gastric proton pump, on the surface of stomach parietal cells. This inhibition stops the final step of acid secretion, leading to a sustained decrease in gastric acidity and allowing damaged tissue to heal.

The appropriate dose of Ortanol 20 Plus is determined by the prescribing clinician based on the specific indication, severity of disease and patient factors. Healthcare professionals set the regimen and duration according to current clinical guidelines and individual patient needs.

Omeprazole is classified as pregnancy category B in many regions, indicating no proven risk in animal studies but limited human data. It may be used during pregnancy only if clearly needed. Breastfeeding mothers should consult a healthcare provider, as small amounts can pass into milk.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Ortanol 20 Plus (omeprazole) belongs to the proton pump inhibitor class, which provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with newer PPIs like esomeprazole, omeprazole offers similar efficacy at a generally lower cost.

Store Ortanol 20 Plus at temperatures below 25 °C in its original packaging. Protect the tablets from moisture, heat and direct sunlight to maintain stability and potency throughout its shelf life.

Ortanol 20 Plus is taken orally, usually as a whole tablet with a glass of water. It is commonly recommended to swallow the tablet before a meal, but patients should follow the specific timing instructions provided by their prescriber.

Serious but uncommon risks include Clostridioides difficile‑associated colitis, severe low‑magnesium levels, acute interstitial nephritis, and rare hypersensitivity reactions such as Stevens‑Johnson syndrome. Patients should seek medical attention if they experience persistent diarrhea, muscle cramps, rash or unexplained kidney problems.

Individuals with known hypersensitivity to omeprazole or any component of the tablet should avoid it. Caution is also advised for patients with severe liver impairment, those requiring certain antiplatelet drugs like clopidogrel, and anyone for whom long‑term acid suppression is contraindicated.